title: No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis.
authors.forename: Markus
authors.initials: M
authors.lastname: Ditschkowski
authors.forename: Ahmet H
authors.initials: AH
authors.lastname: Elmaagacli
authors.forename: Rudolf
authors.initials: R
authors.lastname: Trenschel
authors.forename: Nina K
authors.initials: NK
authors.lastname: Steckel
authors.forename: Michael
authors.initials: M
authors.lastname: Koldehoff
authors.forename: Dietrich W
authors.initials: DW
authors.lastname: Beelen
mesh_terms: D019943:Amino Acid Substitution; D015415:Biomarkers; D018380:Hematopoietic Stem Cell Transplantation / Q000706:statistics & numerical data*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics* / Q000502:physiology; D053208:Kaplan-Meier Estimate; D020125:Mutation, Missense; D017354:Point Mutation; D011087:Polycythemia Vera / Q000201:enzymology / Q000235:genetics* / Q000401:mortality / Q000601:surgery; D055728:Primary Myelofibrosis / Q000201:enzymology / Q000235:genetics* / Q000401:mortality / Q000601:surgery; D011379:Prognosis; D012008:Recurrence; D012306:Risk; D016019:Survival Analysis; D013920:Thrombocythemia, Essential / Q000201:enzymology / Q000235:genetics* / Q000401:mortality / Q000601:surgery; D014184:Transplantation, Homologous / Q000706:statistics & numerical data; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D053614:Janus Kinase 2